Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Acrivon Therapeutics, Inc.(ACRV US)

ProfileFinancialsChartingShort InterestEmployees

Overview

Profile

Financials & Metrics

FinancialsChartingShort InterestEmployees
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Acrivon Therapeutics, Inc.(ACRV US)

ProfileFinancialsChartingShort InterestEmployees

Overview

Profile

Financials & Metrics

FinancialsChartingShort InterestEmployees
ACRV US​
Ask AI
ACRV US​
Ask AI

Financials

Income StatementBalance Sheet

Cash Flow

Millions USD (ex. Per Share)
FY202012/31/2020
FY202112/31/2021
FY202212/31/2022
FY202312/31/2023
FY202412/31/2024
FY202512/31/2025
Last 12M03/31/2026
Net Income-60.4-80.6-77.9-77.3
Depreciation & Amortization0.51.00.91.2
Stock Based Compensation11.614.314.713.1
Change in Working Capital8.12.4-2.4-3.1
Other Non-Cash Items1.1-2.81.05.3
Net Cash from Operating Activities-42.6-65.7-63.7-64.7
-Investments in Property, Plant & Equipment-1.3-2.8-1.7-1.6
-Acquisitions Net----
-Purchases of Investments-56.5-202.9-81.7-78.4
Sales/Maturities of Investments108.5153.9149.5140.0
Other Investing Activities----
Net Cash from Investing Activities50.7-51.866.160.0
Net Debt Issuance----
Net Stock Issuance-0.370.00.0-
-Net Dividends Paid----
Other Financing Activities-1.351.0-0.8-0.4
Net Cash from Financing Activities-1.6121.0-0.7-0.4
Effect of Forex Changes---0.0
Net Change in Cash6.53.61.7-5.1
Cash at End of Period36.440.041.7153.3
Operating Cash Flow-42.6-65.7-63.7-64.7
-Capital Expenditure-1.3-2.8-1.7-1.6
Free Cash Flow-43.9-68.4-65.3-66.3

Financials

Income StatementBalance Sheet

Cash Flow

Millions USD (ex. Per Share)
FY202012/31/2020
FY202112/31/2021
FY202212/31/2022
FY202312/31/2023
FY202412/31/2024
FY202512/31/2025
Last 12M03/31/2026
Net Income-60.4-80.6-77.9-77.3
Depreciation & Amortization0.51.00.91.2
Stock Based Compensation11.614.314.713.1
Change in Working Capital8.12.4-2.4-3.1
Other Non-Cash Items1.1-2.81.05.3
Net Cash from Operating Activities-42.6-65.7-63.7-64.7
-Investments in Property, Plant & Equipment-1.3-2.8-1.7-1.6
-Acquisitions Net----
-Purchases of Investments-56.5-202.9-81.7-78.4
Sales/Maturities of Investments108.5153.9149.5140.0
Other Investing Activities----
Net Cash from Investing Activities50.7-51.866.160.0
Net Debt Issuance----
Net Stock Issuance-0.370.00.0-
-Net Dividends Paid----
Other Financing Activities-1.351.0-0.8-0.4
Net Cash from Financing Activities-1.6121.0-0.7-0.4
Effect of Forex Changes---0.0
Net Change in Cash6.53.61.7-5.1
Cash at End of Period36.440.041.7153.3
Operating Cash Flow-42.6-65.7-63.7-64.7
-Capital Expenditure-1.3-2.8-1.7-1.6
Free Cash Flow-43.9-68.4-65.3-66.3